In RCC cells, however, METTL14 depletion results in the high expression of P2RX6 via the ATP‐P2RX6‐Ca2+‐p‐ERK1/2‐MMP9 signaling pathway and finally accelerates the aggressiveness of RCC cells.68 This evidence concerns the gene MAPK3 and renal cell carcinoma.